GeneDx Holdings: Peers

The FY2025 (Dec) proxy of GeneDx Holdings names 17 peer companies for pay. Among GeneDx Holdings and these peers, CEO pay was 3rd highest of 10 and total shareholder return was the highest of 10.

3rd highest of 10in GeneDx Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$4.0M$15.0M

1st highest of 10in GeneDx Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$5$1,494

Pay peer group, FY2025 (Dec) proxy

Natera
Twist Bioscience
Ultragenyx Pharmaceutical
Mirum Pharmaceuticals
Adaptive Biotechnologies
Veracyte
CareDx
10x Genomics
Health Catalyst
AxogenNot disclosedNot disclosed
Castle BiosciencesNot disclosedNot disclosed
CerusNot disclosedNot disclosed
Fulgent GeneticsNot disclosedNot disclosed
Myriad GeneticsNot disclosedNot disclosed
NeogenomicsNot disclosedNot disclosed
Pacific Biosciences of CaliforniaNot disclosedNot disclosed
Standard BioToolsNot disclosedNot disclosed
17 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.